BPH Clinical Trial
Official title:
Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for Benign Prostatic Hyperplasia
This prospective, multicenter, two-arm, 1:1 randomized controlled trial (RCT) will enroll approximately 250 males at approximately 25 sites located within the United States. All enrolled subjects will be 45 years of age or older diagnosed with symptomatic benign prostatic hyperplasia (BPH). They will be randomized to one of two readily available, marketed BPH therapies; Prostatic Urethral Lift procedure with the UroLift System (PUL Arm) or 0.4mg tamsulosin HCl (MED Arm).
This prospective, multicenter, two-arm, 1:1 randomized controlled trial (RCT) will enroll approximately 250 males at approximately 25 sites located within the United States. All enrolled subjects will be 45 years of age or older diagnosed with symptomatic benign prostatic hyperplasia (BPH). They will be randomized to one of two readily available, marketed BPH therapies; Prostatic Urethral Lift procedure with the UroLift System (PUL Arm) or 0.4mg tamsulosin HCl (MED Arm).Men 45 or older diagnosed with symptomatic benign prostatic hyperplasia (BPH). BPH symptoms may range from mild (8) to severe (35) on the IPSS scale. All enrolled men must meet selection criteria and be candidates for therapy with both UroLift System and 0.4 mg tamsulosin HCl. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02974751 -
Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue
|
||
| Terminated |
NCT04398966 -
Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia
|
N/A | |
| Completed |
NCT04029012 -
Penthrox in Rezūm BPH
|
Phase 4 | |
| Recruiting |
NCT03912558 -
Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients.
|
N/A | |
| Completed |
NCT00527488 -
Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
|
Phase 2 | |
| Recruiting |
NCT06323109 -
US Imaging for the Assessment of LUTS
|
||
| Completed |
NCT05628025 -
Simulation-Based Enucleation Training: Initial Experience Using 3D-printed Organ Phantoms
|
||
| Completed |
NCT00407329 -
Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia
|
N/A | |
| Completed |
NCT00256399 -
Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)
|
N/A | |
| Terminated |
NCT03994263 -
A Prospective Study to Observe the Mechanism of Action of the MediTate iTind in Subjects With Symptomatic BPH With MRI
|
N/A | |
| Completed |
NCT03772808 -
Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS)
|
N/A | |
| Completed |
NCT05818670 -
Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study
|
Phase 4 | |
| Withdrawn |
NCT02961114 -
Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04198103 -
Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia
|
N/A | |
| Completed |
NCT00696761 -
The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients
|
Phase 4 | |
| Completed |
NCT00199550 -
Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)
|
Phase 4 | |
| Completed |
NCT02702947 -
Efficacy of Prunus Domestica Extract in BPH
|
Phase 4 | |
| Completed |
NCT00154843 -
A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation
|
Phase 2 | |
| Completed |
NCT00037141 -
Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05620784 -
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
|
Phase 3 |